Viela Bio, Inc.
DelistedCIK 1734517fmd_1G9YE8CW8HVDHQDFPYAWGCZJSVManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Dec 31, 2020, 12 periods
| Line item | FY2018 | FY2019 | FY2020 |
|---|---|---|---|
| Total revenues | – | 50 | 12 |
| Research and development | 42 | 105 | 103 |
| Selling, general and administrative | 7 | 35 | 60 |
| Total operating expenses | 192 | 140 | 166 |
| Operating income | (192) | (90) | (154) |
| Other non-operating income (expense) | 2 | 3 | 3 |
| Income tax expense | 0 | 0 | 0 |
| Net income | (190) | (86) | (151) |